Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 8Tumor-Agnostic 4CNS 4Genitourinary 3Gastrointestinal 3Breast 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Neoplasms, Plasma Cell 1Lymphoma 1

Interventions

Dexamethasone 262Lenalidomide 157daratumumab 135Bortezomib 113pomalidomide 89Calcium Dobesilate 86Cyclophosphamide 84carfilzomib 76Specimen Handling 46isatuximab 44fludarabine 43Biopsy 43belantamab mafodotin 41Magnetic Resonance Spectroscopy 38dexamethasone acetate 34dexamethasone 21-phosphate 34auricularum 33Melphalan 32talquetamab 29ixazomib 27iberdomide 27fludarabine phosphate 24selinexor 22elotuzumab 21Whole-Body Irradiation 17X-Rays 15venetoclax 14Mycophenolic Acid 13tocilizumab 12Stem Cell Transplantation 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Restraint, Physical × Plasma cell × 1 year × Clear all
NCT04194840 2025-08-05

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Case Comprehensive Cancer Center

Phase NA Completed
20 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡